Vigabatrin (Sabril – Merrell) is a new kind of anti-convulsant marketed last year for the treatment of epilepsy uncontrolled by other drugs. We look at its efficacy and toxicity, and discuss how it should be used in practice.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.